- Tytuł:
-
[
Chinese expert consensus on iruplinalkib for the treatment of locally advanced or metastatic ALK-positive non-small cell lung cancer (2024 edition)]. - Corporate Authors:
-
Medical Oncology Branch of China International Exchange and Promotive Association for Medical and Health Care
Chinese Association for Clinical Oncologists - Źródło:
-
Zhonghua zhong liu za zhi [
Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2024 Mar 23; Vol. 46 (3), pp. 189-205. - Typ publikacji:
- English Abstract; Journal Article
- MeSH Terms:
-
Carcinoma , Non-Small-Cell Lung*/drug therapyCarcinoma , Non-Small-Cell Lung*/geneticsCarcinoma , Non-Small-Cell Lung*/pathology
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Antineoplastic Agents*/adverse effects
Amides*
Propionates*
Humans ; Crizotinib/therapeutic use ; Consensus ; Receptor Protein-Tyrosine Kinases ; Protein Kinase Inhibitors/adverse effects
Czasopismo naukowe